Compound ID | 791
Class: Macrolide
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Propionibacterium |
| Description: | Schmitt-Hoffmann A, Urwyler H, Wuermlin C, et al. BAL19403: preclinical data. 46th-Intersci-Conf-Antimicrobial-Agents-Chemother 2006;234 |
| Institute where first reported: | Basilea Pharmaceutica AG, Switzerland |
| Year first mentioned: | 2006 |
| Highest development stage: | Phase 1 |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/11528098 |
| Guide to Pharmacology: | BAL19403 |
| Citation: | https://doi.org/10.1128/aac.00062-07 |